These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
430 related articles for article (PubMed ID: 34012113)
1. MIR-NATs repress MAPT translation and aid proteostasis in neurodegeneration. Simone R; Javad F; Emmett W; Wilkins OG; Almeida FL; Barahona-Torres N; Zareba-Paslawska J; Ehteramyan M; Zuccotti P; Modelska A; Siva K; Virdi GS; Mitchell JS; Harley J; Kay VA; Hondhamuni G; Trabzuni D; Ryten M; Wray S; Preza E; Kia DA; Pittman A; Ferrari R; Manzoni C; Lees A; Hardy JA; Denti MA; Quattrone A; Patani R; Svenningsson P; Warner TT; Plagnol V; Ule J; de Silva R Nature; 2021 Jun; 594(7861):117-123. PubMed ID: 34012113 [TBL] [Abstract][Full Text] [Related]
2. Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy. Ferrer I; Andrés-Benito P; Zelaya MV; Aguirre MEE; Carmona M; Ausín K; Lachén-Montes M; Fernández-Irigoyen J; Santamaría E; Del Rio JA Acta Neuropathol; 2020 Apr; 139(4):735-771. PubMed ID: 31907603 [TBL] [Abstract][Full Text] [Related]
3. Tau alternative splicing in familial and sporadic tauopathies. Niblock M; Gallo JM Biochem Soc Trans; 2012 Aug; 40(4):677-80. PubMed ID: 22817715 [TBL] [Abstract][Full Text] [Related]
4. The seeds of its regulation: Natural antisense transcripts as single-gene control switches in neurodegenerative disorders. Lahiri DK; Maloney B; Wang R; White FA; Sambamurti K; Greig NH; Counts SE Ageing Res Rev; 2024 Aug; 99():102336. PubMed ID: 38740308 [TBL] [Abstract][Full Text] [Related]
5. Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models. Hannan SB; Dräger NM; Rasse TM; Voigt A; Jahn TR J Neurochem; 2016 Apr; 137(1):12-25. PubMed ID: 26756400 [TBL] [Abstract][Full Text] [Related]
6. A novel tau mutation, p.K317N, causes globular glial tauopathy. Tacik P; DeTure M; Lin WL; Sanchez Contreras M; Wojtas A; Hinkle KM; Fujioka S; Baker MC; Walton RL; Carlomagno Y; Brown PH; Strongosky AJ; Kouri N; Murray ME; Petrucelli L; Josephs KA; Rademakers R; Ross OA; Wszolek ZK; Dickson DW Acta Neuropathol; 2015 Aug; 130(2):199-214. PubMed ID: 25900293 [TBL] [Abstract][Full Text] [Related]
7. iPSC-induced neurons with the V337M MAPT mutation are selectively vulnerable to caspase-mediated cleavage of tau and apoptotic cell death. Theofilas P; Wang C; Butler D; Morales DO; Petersen C; Ambrose A; Chin B; Yang T; Khan S; Ng R; Kayed R; Karch CM; Miller BL; Gestwicki JE; Gan L; Temple S; Arkin MR; Grinberg LT Mol Cell Neurosci; 2024 Sep; 130():103954. PubMed ID: 39032719 [TBL] [Abstract][Full Text] [Related]
8. Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations. Iovino M; Agathou S; González-Rueda A; Del Castillo Velasco-Herrera M; Borroni B; Alberici A; Lynch T; O'Dowd S; Geti I; Gaffney D; Vallier L; Paulsen O; Káradóttir RT; Spillantini MG Brain; 2015 Nov; 138(Pt 11):3345-59. PubMed ID: 26220942 [TBL] [Abstract][Full Text] [Related]
12. Extracellular Tau levels are influenced by variability in Tau that is associated with tauopathies. Karch CM; Jeng AT; Goate AM J Biol Chem; 2012 Dec; 287(51):42751-62. PubMed ID: 23105105 [TBL] [Abstract][Full Text] [Related]
13. Brief update on different roles of tau in neurodegeneration. Ittner A; Ke YD; van Eersel J; Gladbach A; Götz J; Ittner LM IUBMB Life; 2011 Jul; 63(7):495-502. PubMed ID: 21698753 [TBL] [Abstract][Full Text] [Related]
14. MAPT mutations, tauopathy, and mechanisms of neurodegeneration. Strang KH; Golde TE; Giasson BI Lab Invest; 2019 Jul; 99(7):912-928. PubMed ID: 30742061 [TBL] [Abstract][Full Text] [Related]
15. Familial tauopathy with P364S MAPT mutation: clinical course, neuropathology and ultrastructure of neuronal tau inclusions. Štrafela P; Pleško J; Magdič J; Koritnik B; Zupan A; Glavač D; Bresjanac M; Popović M Neuropathol Appl Neurobiol; 2018 Oct; 44(6):550-562. PubMed ID: 29215752 [TBL] [Abstract][Full Text] [Related]
17. Disentangling the role of the tau gene locus in sporadic tauopathies. Vandrovcova J; Anaya F; Kay V; Lees A; Hardy J; de Silva R Curr Alzheimer Res; 2010 Dec; 7(8):726-34. PubMed ID: 20704554 [TBL] [Abstract][Full Text] [Related]
18. Tau silencing by siRNA in the P301S mouse model of tauopathy. Xu H; Rösler TW; Carlsson T; de Andrade A; Fiala O; Hollerhage M; Oertel WH; Goedert M; Aigner A; Höglinger GU Curr Gene Ther; 2014; 14(5):343-51. PubMed ID: 25687501 [TBL] [Abstract][Full Text] [Related]
19. The role of tau (MAPT) in frontotemporal dementia and related tauopathies. Rademakers R; Cruts M; van Broeckhoven C Hum Mutat; 2004 Oct; 24(4):277-95. PubMed ID: 15365985 [TBL] [Abstract][Full Text] [Related]